CD40, also known as TNFSF5, is a type I transmembrane protein and member of the TNF receptor family. The binding of CD40L (CD154) on TH cells to CD40 activates antigen presenting cells and induces a variety of downstream effects. CD40 is expressed on B cells, dendritic cells, monocytes, thymic epithelial cells and, at low levels, on T cells. Signaling though CD40 plays an important role in the proliferation and differentiation of B cells and is critical for immunoglobulin (Ig) class switching. The membrane-anchored CD40L is expressed almost exclusively on activated CD4+ T lymphocytes. Failure to express CD40L leads to "immunodeficiency with hyper-IgM", a disease characterized by failure to produce IgG, IgA and IgE. Some of the early intracellular signaling by the CD4-CD40L system includes the association of the CD40 with TRAFs and the activation of various kinases (4). Adaptor protein TNFR2 interacts with this receptor and serves as a mediator of the signal transduction. The interaction of CD4-CD40L is found to be necessary for amyloid-beta-induced microglial activation, and thus is thought to be an early event in Alzheimer disease pathogenesis.
Catalog | IV0116 |
Product Name | InVivoPro Anti-Mouse CD40 in vivo antibody, Clone FGK45 |
Size | 1mg/5mg/25mg/50mg/100mg |
Isotype | Rat IgG2a |
Clone | FGK45 |
Target | CD40 |
Other Names | CD40, Bp50, TNFRSF5 |
Isotype Control Catalog Code | IV0105 or Rat IgG2a Isotype Control |
Dilution Buffer | PBS, pH 7.2, contains no stabilizers or preservatives |
Reactivity | Mouse |
Host Species | Rat |
How much antibody to use in vivo | 200-500 μg per mouse; or 10-20 mg/kg. This range is based off the most recent publication data using the FGK45 clone in vivo. Each investigator should determine their own optimal working dilution for specific applications. |
Background(ichorbio) | CD40, also known as TNFSF5, is a type I transmembrane protein and member of the TNF receptor family. The binding of CD40L (CD154) on TH cells to CD40 activates antigen presenting cells and induces a variety of downstream effects. CD40 is expressed on B cells, dendritic cells, monocytes, thymic epithelial cells and, at low levels, on T cells. Signaling though CD40 plays an important role in the proliferation and differentiation of B cells and is critical for immunoglobulin (Ig) class switching. The membrane-anchored CD40L is expressed almost exclusively on activated CD4+ T lymphocytes. Failure to express CD40L leads to "immunodeficiency with hyper-IgM", a disease characterized by failure to produce IgG, IgA and IgE. Some of the early intracellular signaling by the CD4-CD40L system includes the association of the CD40 with TRAFs and the activation of various kinases (4). Adaptor protein TNFR2 interacts with this receptor and serves as a mediator of the signal transduction. The interaction of CD4-CD40L is found to be necessary for amyloid-beta-induced microglial activation, and thus is thought to be an early event in Alzheimer disease pathogenesis. |
Applications | In vivo CD40 activation, in vitro B cell stimulation/activation, Flow cytometry |
Purification | protein A or G |
Storage | This antibody is stable for at least 2 months when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at -20°C or -80°C. Avoid repeated freeze thaw cycles. |
Shipping | 2-8°C with blue ice |
Concentration | Lot specific, generally ≥ 5.0 mg/ml |
Shelf Life | 12 months from the date of receipt if stored as recommended |
Formulation | PBS Buffer, PH 7.2, with no carrier protein, or preservatives. |
Sterility | 0.2 μM filtered |
Endotoxin | ≤ 1.0 EU/mg, by the LAL method |
Purity | 99% |
Frentsch, Marco et al. "CD40L expression permits CD8+ T cells to execute immunologic helper functions". Blood vol. 122,3 (2013): 405-12.
Sharma, Madhav D et al. "Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice". Immunity vol. 33,6 (2010): 942-54.
Van Belle, Tom L et al. "Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets". Immunity vol. 36,6 (2012): 1060-72.